The XPO1 inhibitor selinexor ameliorates bleomycin-induced pulmonary fibrosis in mice via GBP5/NLRP3 inflammasome signaling
Article in International Immunopharmacology (February 2024)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Article in International Immunopharmacology (February 2024)
Article in Pharmaceutics (July 2023)